annual book value:
$2.59B+$357.70M(+16.03%)Summary
- As of today (April 12, 2025), NBIX annual book value is $2.59 billion, with the most recent change of +$357.70 million (+16.03%) on December 1, 2024.
- During the last 3 years, NBIX annual book value has risen by +$1.22 billion (+88.48%).
- NBIX annual book value is now at all-time high.
Performance
NBIX Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$2.59B-$129.20M(-4.75%)Summary
- As of today (April 12, 2025), NBIX quarterly book value is $2.59 billion, with the most recent change of -$129.20 million (-4.75%) on December 1, 2024.
- Over the past year, NBIX quarterly book value has increased by +$203.60 million (+8.53%).
- NBIX quarterly book value is now -4.75% below its all-time high of $2.72 billion, reached on September 30, 2024.
Performance
NBIX quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
NBIX Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.0% | +8.5% |
| 3 y3 years | +88.5% | +8.5% |
| 5 y5 years | +306.6% | +8.5% |
NBIX Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.5% | -4.8% | +86.2% |
| 5 y | 5-year | at high | +306.6% | -4.8% | +269.8% |
| alltime | all time | at high | >+9999.0% | -4.8% | >+9999.0% |
Neurocrine Biosciences Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.59B(+16.0%) | $2.59B(-4.8%) |
| Sep 2024 | - | $2.72B(+8.4%) |
| Jun 2024 | - | $2.51B(+5.2%) |
| Mar 2024 | - | $2.39B(+6.9%) |
| Dec 2023 | $2.23B(+30.7%) | $2.23B(+11.5%) |
| Sep 2023 | - | $2.00B(+8.0%) |
| Jun 2023 | - | $1.85B(+10.0%) |
| Mar 2023 | - | $1.68B(-1.4%) |
| Dec 2022 | $1.71B(+24.3%) | $1.71B(+10.6%) |
| Sep 2022 | - | $1.54B(+8.5%) |
| Jun 2022 | - | $1.42B(+2.3%) |
| Mar 2022 | - | $1.39B(+1.2%) |
| Dec 2021 | $1.37B(+22.0%) | $1.37B(+2.1%) |
| Sep 2021 | - | $1.35B(+5.2%) |
| Jun 2021 | - | $1.28B(+6.1%) |
| Mar 2021 | - | $1.21B(+7.1%) |
| Dec 2020 | $1.13B(+76.8%) | $1.13B(+40.0%) |
| Sep 2020 | - | $804.30M(-3.2%) |
| Jun 2020 | - | $831.20M(+18.7%) |
| Mar 2020 | - | $700.30M(+10.0%) |
| Dec 2019 | $636.90M(+32.5%) | $636.90M(+10.9%) |
| Sep 2019 | - | $574.51M(+18.8%) |
| Jun 2019 | - | $483.71M(+18.2%) |
| Mar 2019 | - | $409.27M(-14.9%) |
| Dec 2018 | $480.76M(+29.2%) | $480.76M(+7.4%) |
| Sep 2018 | - | $447.51M(+18.6%) |
| Jun 2018 | - | $377.44M(+3.6%) |
| Mar 2018 | - | $364.49M(-2.1%) |
| Dec 2017 | $372.14M(+18.2%) | $372.14M(+7.1%) |
| Sep 2017 | - | $347.51M(+0.7%) |
| Jun 2017 | - | $345.24M(+39.7%) |
| Mar 2017 | - | $247.14M(-21.5%) |
| Dec 2016 | $314.88M(-25.8%) | $314.88M(-10.5%) |
| Sep 2016 | - | $351.65M(-7.7%) |
| Jun 2016 | - | $381.04M(-7.7%) |
| Mar 2016 | - | $412.96M(-2.7%) |
| Dec 2015 | $424.45M(+103.4%) | $424.45M(-5.0%) |
| Sep 2015 | - | $446.94M(-4.3%) |
| Jun 2015 | - | $466.94M(-3.7%) |
| Mar 2015 | - | $484.73M(+132.3%) |
| Dec 2014 | $208.70M(+73.3%) | $208.70M(-6.8%) |
| Sep 2014 | - | $224.04M(-5.4%) |
| Jun 2014 | - | $236.84M(-4.1%) |
| Mar 2014 | - | $247.06M(+105.2%) |
| Dec 2013 | $120.41M(-22.0%) | $120.41M(-6.9%) |
| Sep 2013 | - | $129.29M(-4.9%) |
| Jun 2013 | - | $136.02M(-6.2%) |
| Mar 2013 | - | $144.95M(-6.1%) |
| Dec 2012 | $154.37M(+156.9%) | $154.37M(+7.7%) |
| Sep 2012 | - | $143.31M(-1.0%) |
| Jun 2012 | - | $144.73M(+0.6%) |
| Mar 2012 | - | $143.83M(+139.4%) |
| Dec 2011 | $60.08M(+210.6%) | $60.08M(+4.0%) |
| Sep 2011 | - | $57.75M(+126.0%) |
| Jun 2011 | - | $25.56M(+11.2%) |
| Mar 2011 | - | $22.99M(+18.9%) |
| Dec 2010 | $19.34M | $19.34M(+16.2%) |
| Sep 2010 | - | $16.65M(+34.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $12.41M(-25.8%) |
| Mar 2010 | - | $16.72M(+322.9%) |
| Dec 2009 | $3.95M(-89.2%) | $3.95M(+267.8%) |
| Sep 2009 | - | $1.07M(-85.4%) |
| Jun 2009 | - | $7.35M(-61.6%) |
| Mar 2009 | - | $19.11M(-48.0%) |
| Dec 2008 | $36.77M(-69.0%) | $36.77M(-42.2%) |
| Sep 2008 | - | $63.65M(-20.3%) |
| Jun 2008 | - | $79.84M(-19.1%) |
| Mar 2008 | - | $98.67M(-16.9%) |
| Dec 2007 | $118.70M(-62.3%) | $118.70M(-51.5%) |
| Sep 2007 | - | $244.95M(-9.0%) |
| Jun 2007 | - | $269.05M(-7.8%) |
| Mar 2007 | - | $291.70M(-7.3%) |
| Dec 2006 | $314.72M(-19.3%) | $314.72M(-3.6%) |
| Sep 2006 | - | $326.48M(-9.8%) |
| Jun 2006 | - | $361.77M(-5.7%) |
| Mar 2006 | - | $383.83M(-1.6%) |
| Dec 2005 | $390.10M(-0.9%) | $390.10M(-3.4%) |
| Sep 2005 | - | $403.74M(+8.5%) |
| Jun 2005 | - | $372.02M(-0.7%) |
| Mar 2005 | - | $374.72M(-4.9%) |
| Dec 2004 | $393.83M(+0.7%) | $393.83M(-4.5%) |
| Sep 2004 | - | $412.56M(+0.2%) |
| Jun 2004 | - | $411.54M(-3.3%) |
| Mar 2004 | - | $425.40M(+8.8%) |
| Dec 2003 | $391.12M(+74.4%) | $391.12M(+1.1%) |
| Sep 2003 | - | $386.83M(+84.2%) |
| Jun 2003 | - | $209.97M(-2.4%) |
| Mar 2003 | - | $215.21M(-4.0%) |
| Dec 2002 | $224.25M(-27.8%) | $224.25M(-13.7%) |
| Sep 2002 | - | $259.83M(-6.3%) |
| Jun 2002 | - | $277.23M(-5.7%) |
| Mar 2002 | - | $293.93M(-5.3%) |
| Dec 2001 | $310.39M(+90.2%) | $310.39M(+113.3%) |
| Sep 2001 | - | $145.53M(+1.9%) |
| Jun 2001 | - | $142.87M(-6.8%) |
| Mar 2001 | - | $153.29M(-6.1%) |
| Dec 2000 | $163.21M(+69.3%) | $163.21M(+100.4%) |
| Sep 2000 | - | $81.44M(-6.2%) |
| Jun 2000 | - | $86.85M(-5.6%) |
| Mar 2000 | - | $92.04M(-4.5%) |
| Dec 1999 | $96.40M(+33.9%) | $96.40M(+62.6%) |
| Sep 1999 | - | $59.30M(-6.3%) |
| Jun 1999 | - | $63.30M(-6.9%) |
| Mar 1999 | - | $68.00M(-5.6%) |
| Dec 1998 | $72.00M(-13.5%) | $72.00M(-8.5%) |
| Sep 1998 | - | $78.70M(+0.4%) |
| Jun 1998 | - | $78.40M(-4.6%) |
| Mar 1998 | - | $82.20M(-1.2%) |
| Dec 1997 | $83.20M(+14.3%) | $83.20M(+6.0%) |
| Sep 1997 | - | $78.50M(+1.4%) |
| Jun 1997 | - | $77.40M(+0.3%) |
| Mar 1997 | - | $77.20M(+6.0%) |
| Dec 1996 | $72.80M | $72.80M(+6.7%) |
| Sep 1996 | - | $68.20M(-0.4%) |
| Jun 1996 | - | $68.50M(+183.1%) |
| Mar 1996 | - | $24.20M |
FAQ
- What is Neurocrine Biosciences annual book value?
- What is the all time high annual book value for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual book value year-on-year change?
- What is Neurocrine Biosciences quarterly book value?
- What is the all time high quarterly book value for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly book value year-on-year change?
What is Neurocrine Biosciences annual book value?
The current annual book value of NBIX is $2.59B
What is the all time high annual book value for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual book value is $2.59B
What is Neurocrine Biosciences annual book value year-on-year change?
Over the past year, NBIX annual book value has changed by +$357.70M (+16.03%)
What is Neurocrine Biosciences quarterly book value?
The current quarterly book value of NBIX is $2.59B
What is the all time high quarterly book value for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly book value is $2.72B
What is Neurocrine Biosciences quarterly book value year-on-year change?
Over the past year, NBIX quarterly book value has changed by +$203.60M (+8.53%)